A case report of olanzapine-induced hypersensitivity syndrome

被引:49
作者
Raz, A
Bergman, R
Eilam, O
Yungerman, T
Hayek, T
机构
[1] Rambam Med Ctr, Dept Med E, IL-31096 Haifa, Israel
[2] Rambam Med Ctr, Dept Dermatol, IL-31096 Haifa, Israel
[3] Rambam Med Ctr, Dept Psychiat, IL-31096 Haifa, Israel
关键词
olanzapine; hypersensitivity syndrome;
D O I
10.1097/00000441-200102000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypersensitivity syndrome is defined as a drug-induced complex of symptoms consisting of fever, rash, and internal organ involvement. The hypersensitivity syndrome is well recognized as being caused by anticonvulsants. Olanzapine is an atypical antipsychotic agent whose side effects include sedation, weight gain, and increased creatinine kinase and transaminase levels. To date, there have been no reports of hypersensitivity syndrome related to this drug. A 34-year-old man developed a severe generalized pruritic skin eruption, fever, eosinophilia, and toxic hepatitis 60 days after ingestion of olanzapine. After termination of olanzapine treatment, the fever resolved, the skin rash was reduced, eosinophil count was reduced to normal, and the transaminase levels were markedly reduced. Clinical features and the results of skin and liver biopsies indicated that the patient developed hypersensitivity syndrome caused by olanzapine.
引用
收藏
页码:156 / 158
页数:3
相关论文
共 13 条
[1]  
Beasley CM, 1997, J CLIN PSYCHIAT, V58, P7
[2]   Olanzapine: A serotonin-dopamine-receptor antagonist for antipsychotic therapy [J].
Bever, KA ;
Perry, PJ .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (10) :1003-1016
[3]   Hypersensitivity reaction in a child due to lamotrigine [J].
Brown, TS ;
Appel, JE ;
Kasteler, JS ;
Callen, JP .
PEDIATRIC DERMATOLOGY, 1999, 16 (01) :46-49
[4]  
Conger LA, 1996, CUTIS, V57, P223
[5]   Olanzapine - A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses [J].
Fulton, B ;
Goa, KL .
DRUGS, 1997, 53 (02) :281-298
[6]   Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocytosis, and liver dysfunction [J].
Higa, K ;
Hirata, K ;
Dan, K .
PAIN, 1997, 73 (01) :97-99
[7]   Myocarditis and cardiomyopathy associated with clozapine [J].
Kilian, JG ;
Kerr, K ;
Lawrence, C ;
Celermajer, DS .
LANCET, 1999, 354 (9193) :1841-1845
[8]   Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials [J].
Leucht, S ;
Pitschel-Walz, G ;
Abraham, D ;
Kissling, W .
SCHIZOPHRENIA RESEARCH, 1999, 35 (01) :51-68
[9]   Marked elevation of serum creatine kinase associated with olanzapine therapy [J].
Marcus, EL ;
Vass, A ;
Zislin, J .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (06) :697-700
[10]   Olanzapine in treatment-resistant bipolar disorder [J].
McElroy, SL ;
Frye, M ;
Denicoff, K ;
Altshuler, L ;
Nolen, W ;
Kupka, R ;
Suppes, T ;
Keck, PE ;
Leverich, GS ;
Kmetz, GF ;
Post, RM .
JOURNAL OF AFFECTIVE DISORDERS, 1998, 49 (02) :119-122